Spinal Elements announced the appointment of Susan Denman to the Company's Board of Directors. As a highly respected leader in the industry, Ms. Denman brings to the Board extensive experience in advancing the intersection of business and technology to drive growth. Over the course of her career, Ms. Denman has orchestrated transformative strategies for Johnson & Johnson ("J&J"), Sanofi, Nabisco and JPMorgan Chase.

She currently serves as Managing Partner of the Susan Denman Group, LLC, which provides board, executive and private equity advisory services and executive coaching, and she is currently a member of the Board of Advisors for Trinity Life Sciences and the Digital Advisory Board for Sage Therapeutics. Ms. Denman holds an MBA from The Wharton School, a bachelor's degree from Duke University and an Executive Certificate from MIT. She was recently honored as one of the Top 50 Most Powerful Women in Tech by the National Diversity Council and Tech Inclusion Council.